Pfizer Competitors and Similar CompaniesClear all

Merck's competitors and similar companies include Bausch Health, Astellas Pharma, Boehringer Ingelheim, Merck Group, Sanofi, Takeda, Amgen, Bristol Myers Squibb, Bayer, GSK and Eli Lilly.
Merck
Merck
Merck & Co (also known as Merck Sharp & Dohme) is a healthcare manufacturer and distributor of pharmaceuticals.
Bausch Health
Bausch Health
Bausch Health is a company that develops, manufactures, and markets a range of pharmaceutical, medical device, and over-the-counter (OTC) products.
Astellas Pharma
Astellas Pharma
Astellas Pharma (アステラス製薬株式会社) is a pharmaceutical company focused on the development of drugs and medical solutions.
Boehringer Ingelheim
Boehringer Ingelheim
Boehringer Ingelheim International is a pharmaceutical company specializing in animal health, human pharma, and biopharmaceutical contract manufacturing.
Merck Group
Merck Group
Merck Group is a science and technology company.
Sanofi
Sanofi
Sanofi is a global healthcare company engaged in the research, development, manufacture, and marketing of therapeutic solutions.
Takeda
Takeda
Takeda Pharmaceutical is a biopharmaceutical company engaged in the research, development, production, and commercialization of pharmaceutical products.
Amgen
Amgen
Amgen (formerly known as Applied Molecular Genetics) is a biotechnology company that discovers, develops, manufactures, and delivers human therapeutics.
Bristol Myers Squibb
Bristol Myers Squibb
Bristol-Myers Squibb (BMS) is a company engaged in the discovery, development, licensing, manufacturing, marketing, and distribution of biopharmaceutical products.
Bayer
Bayer
Bayer is a life sciences company specializing in healthcare and nutrition.
GSK
GSK
GSK (GlaxoSmithKline) is a science-led healthcare company that researches, develops, and manufactures pharmaceutical medicines, vaccines, and consumer healthcare products.
Eli Lilly
Eli Lilly
Eli Lilly is a company that discovers, develops, manufactures, and markets pharmaceutical products.
Founding Date
Founding Date
1891
Founding Date
1959
Founding Date
1923
Founding Date
1958
Founding Date
1668
Founding Date
2004
Founding Date
1781
Founding Date
1980
Founding Date
1887
Founding Date
1863
Founding Date
2000
Founding Date
1876
Type
Type
Public
Type
Public
Type
Public
Type
Subsidiary
Type
Public
Type
Public
Type
Public
Type
Public
Type
Public
Type
Public
Type
Public
Type
Public
Tags
Locations
Locations
Rahway, US HQ
Hydra, DZ
Munro, AR
Macquarie Park, AU
Krems An Der Donau, AT
Wien, AT
Bruxelles, BE
see more
Locations
Laval, CA HQ
Buenos Aires, AR
Wien, AT
Sarajevo, BA
Indaiatuba, BR
Porto Alegre, BR
Sao Paulo, BR
see more
Locations
Tokyo, JP HQ
Macquarie Park, AU
Wien, AT
Vilvoorde, BE
São Paulo, BR
Markham, CA
Beijing, CN
see more
Locations
Ingelheim am Rhein, DE HQ
Ouled Fayet, DZ
Munro, AR
Macquarie Park, AU
Wien, AT
Minsk, BY
Bruxelles, BE
see more
Locations
Darmstadt, DE HQ
Buenos Aires, AR
Bayswater, AU
Macquarie Park, AU
Wien, AT
Hoeilaart, BE
Rio De Janeiro, BR
see more
Locations
Paris, FR HQ
Hydra, DZ
Macquarie Park, AU
Wien, AT
Dhaka, BD
Brussel, BE
Geel, BE
see more
Locations
Tokyo, JP HQ
Buenos Aires, AR
The Rocks, AU
Linz, AT
Wien, AT
Wien, AT
Lessines, BE
see more
Locations
Thousand Oaks, US HQ
Hydra, DZ
Vicente López, AR
Sydney, AU
Wien, AT
Diegem, BE
Santo Amaro, BR
see more
Locations
Princeton, US HQ
Mulgrave, AU
Pinewood, AU
Wien, AT
Braine L'alleud, BE
Bruxelles, BE
São Paulo, BR
see more
Locations
Leverkusen, DE HQ
Tirana, AL
Dely Ibrahim, DZ
Luanda, AO
Munro, AR
Pymble, AU
Wien, AT
see more
Locations
Brentford, GB HQ
Boumerdes, DZ
San Fernando, AR
Abbotsford, AU
Boronia, AU
Ermington, AU
Wien, AT
see more
Locations
Indianapolis, US HQ
Buenos Aires, AR
Sydney, AU
Wien, AT
Brussel, BE
São Paulo, BR
Toronto, CA
see more
Employees
Employees
72,0007% increase
Employees
20,270
Employees
14,484
Employees
1,2338% increase
Employees
62,9081% decrease
Employees
86,0886% decrease
Employees
49,095
Employees
25,200
Employees
34,1001% decrease
Employees
99,7231% decrease
Employees
70,2121% increase
Employees
39,00011% increase
Valuation ($)
Valuation ($)
318.6 b
Valuation ($)
2.6 b
Valuation ($)
17.5 b
Valuation ($)
N/A
Valuation ($)
78.1 b
Valuation ($)
N/A
Valuation ($)
42 b
Valuation ($)
171.1 b
Valuation ($)
90.9 b
Valuation ($)
31.3 b
Valuation ($)
N/A
Valuation ($)
697 b
Twitter followers
Twitter followers
225.4 k
Twitter followers
560
Twitter followers
50.4 k
Twitter followers
106.6 k
Twitter followers
24.9 k
Twitter followers
151.6 k
Twitter followers
N/A
Twitter followers
123.5 k
Twitter followers
156.9 k
Twitter followers
184.4 k
Twitter followers
242.6 k
Twitter followers
N/A
Number of tweets (last 30 days)
Number of tweets (last 30 days)
5
Number of tweets (last 30 days)
N/A
Number of tweets (last 30 days)
25
Number of tweets (last 30 days)
3
Number of tweets (last 30 days)
51
Number of tweets (last 30 days)
35
Number of tweets (last 30 days)
N/A
Number of tweets (last 30 days)
91
Number of tweets (last 30 days)
16
Number of tweets (last 30 days)
30
Number of tweets (last 30 days)
50
Number of tweets (last 30 days)
N/A
Average likes per tweet (last 30 days)
Average likes per tweet (last 30 days)
10.2
Average likes per tweet (last 30 days)
N/A
Average likes per tweet (last 30 days)
5.8
Average likes per tweet (last 30 days)
19.3
Average likes per tweet (last 30 days)
5.9
Average likes per tweet (last 30 days)
15.6
Average likes per tweet (last 30 days)
N/A
Average likes per tweet (last 30 days)
4.8
Average likes per tweet (last 30 days)
6.4
Average likes per tweet (last 30 days)
10
Average likes per tweet (last 30 days)
8.2
Average likes per tweet (last 30 days)
N/A
Percentage of tweets with engagement (last 30 days)
Percentage of tweets with engagement (last 30 days)
60%
Percentage of tweets with engagement (last 30 days)
N/A
Percentage of tweets with engagement (last 30 days)
96%
Percentage of tweets with engagement (last 30 days)
100%
Percentage of tweets with engagement (last 30 days)
96.08%
Percentage of tweets with engagement (last 30 days)
91.43%
Percentage of tweets with engagement (last 30 days)
N/A
Percentage of tweets with engagement (last 30 days)
97.8%
Percentage of tweets with engagement (last 30 days)
93.75%
Percentage of tweets with engagement (last 30 days)
73.33%
Percentage of tweets with engagement (last 30 days)
82%
Percentage of tweets with engagement (last 30 days)
N/A

Financial

Revenue (est.)
Revenue (est.)
$60.1b (FY, 2023)
Revenue (est.)
$8.8b (FY, 2023)
Revenue (est.)
¥1.5t (FY, 2023)
Revenue (est.)
€8.9b (FY, 2021)
Revenue (est.)
€21b (FY, 2023)
Revenue (est.)
€43.1b (FY, 2023)
Revenue (est.)
¥4t (FY, 2023)
Revenue (est.)
$28.2b (FY, 2023)
Revenue (est.)
$45b (FY, 2023)
Revenue (est.)
€47.6b (FY, 2023)
Revenue (est.)
£30.3b (FY, 2023)
Revenue (est.)
$34.1b (FY, 2023)
Cost of goods
Cost of goods
$16.1b (FY, 2023)
Cost of goods
N/A
Cost of goods
¥182.6b (FY, 2023)
Cost of goods
€3b (FY, 2021)
Cost of goods
€7.3b (FY, 2023)
Cost of goods
€12.5b (FY, 2023)
Cost of goods
¥579.7b (FY, 2023)
Cost of goods
$8.5b (FY, 2023)
Cost of goods
$10.7b (FY, 2023)
Cost of goods
€7b (FY, 2023)
Cost of goods
£5.8b (FY, 2023)
Cost of goods
$7.1b (FY, 2023)
Gross profit
Gross profit
$44b (FY, 2023)
Gross profit
N/A
Gross profit
¥1.3t (FY, 2023)
Gross profit
€6b (FY, 2021)
Gross profit
€13.9b (FY, 2023)
Gross profit
€34.5b (FY, 2023)
Gross profit
¥3.5t (FY, 2023)
Gross profit
$19.7b (FY, 2023)
Gross profit
$34.3b (FY, 2023)
Gross profit
€42.1b (FY, 2023)
Gross profit
£25.7b (FY, 2023)
Gross profit
$27b (FY, 2023)
Net income
Net income
$377m (FY, 2023)
Net income
($611m) (FY, 2023)
Net income
¥98.7b (FY, 2023)
Net income
€2.2b (FY, 2021)
Net income
€2.8b (FY, 2023)
Net income
€5.6b (FY, 2023)
Net income
¥317b (FY, 2023)
Net income
$6.7b (FY, 2023)
Net income
$8b (FY, 2023)
Net income
(€2.9b) (FY, 2023)
Net income
£5.3b (FY, 2023)
Net income
$5.2b (FY, 2023)

Operating

Countries
Countries
N/A
Countries
N/A
Countries
N/A
Countries
N/A
Countries
66 (FY, 2021)
Countries
N/A
Countries
N/A
Countries
100 (FY, 2020)
Countries
N/A
Countries
83 (FY, 2021)
Countries
92 (FY, 2021)
Countries
120 (FY, 2021)
Filed Trials Products (Vaccines)
Filed Trials Products (Vaccines)
N/A
Filed Trials Products (Vaccines)
N/A
Filed Trials Products (Vaccines)
N/A
Filed Trials Products (Vaccines)
N/A
Filed Trials Products (Vaccines)
N/A
Filed Trials Products (Vaccines)
1 (FY, 2021)
Filed Trials Products (Vaccines)
2 (May, 2022)
Filed Trials Products (Vaccines)
N/A
Filed Trials Products (Vaccines)
N/A
Filed Trials Products (Vaccines)
N/A
Filed Trials Products (Vaccines)
N/A
Filed Trials Products (Vaccines)
N/A
Manufacturing Facilities
Manufacturing Facilities
N/A
Manufacturing Facilities
37 (FY, 2019)
Manufacturing Facilities
N/A
Manufacturing Facilities
N/A
Manufacturing Facilities
N/A
Manufacturing Facilities
N/A
Manufacturing Facilities
N/A
Manufacturing Facilities
N/A
Manufacturing Facilities
8 (FY, 2021)
Manufacturing Facilities
N/A
Manufacturing Facilities
N/A
Manufacturing Facilities
N/A
Phase I Trials Products
Phase I Trials Products
N/A
Phase I Trials Products
N/A
Phase I Trials Products
N/A
Phase I Trials Products
N/A
Phase I Trials Products
N/A
Phase I Trials Products
N/A
Phase I Trials Products
N/A
Phase I Trials Products
20 (FY, 2020)
Phase I Trials Products
N/A
Phase I Trials Products
N/A
Phase I Trials Products
16 (FY, 2021)
Phase I Trials Products
27 (FY, 2019)
Phase I Trials Products (Immunology)
Phase I Trials Products (Immunology)
N/A
Phase I Trials Products (Immunology)
N/A
Phase I Trials Products (Immunology)
1 (Oct, 2020)
Phase I Trials Products (Immunology)
N/A
Phase I Trials Products (Immunology)
N/A
Phase I Trials Products (Immunology)
N/A
Phase I Trials Products (Immunology)
N/A
Phase I Trials Products (Immunology)
N/A
Phase I Trials Products (Immunology)
6 (FY, 2021)
Phase I Trials Products (Immunology)
N/A
Phase I Trials Products (Immunology)
N/A
Phase I Trials Products (Immunology)
N/A
Phase I Trials Products (Oncology)
Phase I Trials Products (Oncology)
N/A
Phase I Trials Products (Oncology)
N/A
Phase I Trials Products (Oncology)
1 (FY, 2020)
Phase I Trials Products (Oncology)
N/A
Phase I Trials Products (Oncology)
N/A
Phase I Trials Products (Oncology)
9 (FY, 2021)
Phase I Trials Products (Oncology)
N/A
Phase I Trials Products (Oncology)
N/A
Phase I Trials Products (Oncology)
20 (FY, 2021)
Phase I Trials Products (Oncology)
N/A
Phase I Trials Products (Oncology)
N/A
Phase I Trials Products (Oncology)
N/A
Phase II Trials Products
Phase II Trials Products
85 (FY, 2022)
Phase II Trials Products
N/A
Phase II Trials Products
N/A
Phase II Trials Products
N/A
Phase II Trials Products
N/A
Phase II Trials Products
N/A
Phase II Trials Products
N/A
Phase II Trials Products
5 (FY, 2020)
Phase II Trials Products
N/A
Phase II Trials Products
N/A
Phase II Trials Products
6 (FY, 2021)
Phase II Trials Products
8 (FY, 2021)
Phase II Trials Products (Immunology)
Phase II Trials Products (Immunology)
N/A
Phase II Trials Products (Immunology)
N/A
Phase II Trials Products (Immunology)
1 (Oct, 2020)
Phase II Trials Products (Immunology)
N/A
Phase II Trials Products (Immunology)
N/A
Phase II Trials Products (Immunology)
N/A
Phase II Trials Products (Immunology)
N/A
Phase II Trials Products (Immunology)
N/A
Phase II Trials Products (Immunology)
6 (FY, 2021)
Phase II Trials Products (Immunology)
N/A
Phase II Trials Products (Immunology)
N/A
Phase II Trials Products (Immunology)
N/A
Phase II Trials Products (Oncology)
Phase II Trials Products (Oncology)
N/A
Phase II Trials Products (Oncology)
N/A
Phase II Trials Products (Oncology)
1 (FY, 2020)
Phase II Trials Products (Oncology)
N/A
Phase II Trials Products (Oncology)
N/A
Phase II Trials Products (Oncology)
12 (FY, 2021)
Phase II Trials Products (Oncology)
N/A
Phase II Trials Products (Oncology)
N/A
Phase II Trials Products (Oncology)
15 (FY, 2021)
Phase II Trials Products (Oncology)
N/A
Phase II Trials Products (Oncology)
N/A
Phase II Trials Products (Oncology)
N/A
Phase III Trials Products
Phase III Trials Products
32 (FY, 2022)
Phase III Trials Products
N/A
Phase III Trials Products
N/A
Phase III Trials Products
N/A
Phase III Trials Products
N/A
Phase III Trials Products
N/A
Phase III Trials Products
N/A
Phase III Trials Products
11 (FY, 2020)
Phase III Trials Products
N/A
Phase III Trials Products
N/A
Phase III Trials Products
11 (FY, 2021)
Phase III Trials Products
10 (FY, 2021)
Phase III Trials Products (Immunology)
Phase III Trials Products (Immunology)
N/A
Phase III Trials Products (Immunology)
N/A
Phase III Trials Products (Immunology)
1 (Oct, 2020)
Phase III Trials Products (Immunology)
N/A
Phase III Trials Products (Immunology)
N/A
Phase III Trials Products (Immunology)
N/A
Phase III Trials Products (Immunology)
N/A
Phase III Trials Products (Immunology)
N/A
Phase III Trials Products (Immunology)
3 (FY, 2021)
Phase III Trials Products (Immunology)
N/A
Phase III Trials Products (Immunology)
N/A
Phase III Trials Products (Immunology)
N/A
Phase III Trials Products (Oncology)
Phase III Trials Products (Oncology)
N/A
Phase III Trials Products (Oncology)
N/A
Phase III Trials Products (Oncology)
4 (Oct, 2020)
Phase III Trials Products (Oncology)
N/A
Phase III Trials Products (Oncology)
N/A
Phase III Trials Products (Oncology)
N/A
Phase III Trials Products (Oncology)
6 (Jul, 2023)
Phase III Trials Products (Oncology)
N/A
Phase III Trials Products (Oncology)
7 (FY, 2021)
Phase III Trials Products (Oncology)
N/A
Phase III Trials Products (Oncology)
N/A
Phase III Trials Products (Oncology)
N/A
Phase III Trials Products (Vaccines)
Phase III Trials Products (Vaccines)
N/A
Phase III Trials Products (Vaccines)
N/A
Phase III Trials Products (Vaccines)
N/A
Phase III Trials Products (Vaccines)
N/A
Phase III Trials Products (Vaccines)
N/A
Phase III Trials Products (Vaccines)
5 (FY, 2021)
Phase III Trials Products (Vaccines)
2 (Jul, 2023)
Phase III Trials Products (Vaccines)
N/A
Phase III Trials Products (Vaccines)
N/A
Phase III Trials Products (Vaccines)
N/A
Phase III Trials Products (Vaccines)
N/A
Phase III Trials Products (Vaccines)
N/A
Products
Products
N/A
Products
1.4 k (FY, 2019)
Products
N/A
Products
73 (Feb, 2024)
Products
300 k (FY, 2021)
Products
N/A
Products
N/A
Products
N/A
Products
N/A
Products
N/A
Products
N/A
Products
N/A
Projects in R&D Pipeline
Projects in R&D Pipeline
N/A
Projects in R&D Pipeline
225 (FY, 2019)
Projects in R&D Pipeline
N/A
Projects in R&D Pipeline
N/A
Projects in R&D Pipeline
N/A
Projects in R&D Pipeline
91 (FY, 2019)
Projects in R&D Pipeline
N/A
Projects in R&D Pipeline
N/A
Projects in R&D Pipeline
N/A
Projects in R&D Pipeline
N/A
Projects in R&D Pipeline
N/A
Projects in R&D Pipeline
N/A
Research and Development Centers
Research and Development Centers
N/A
Research and Development Centers
23 (FY, 2019)
Research and Development Centers
N/A
Research and Development Centers
N/A
Research and Development Centers
N/A
Research and Development Centers
N/A
Research and Development Centers
N/A
Research and Development Centers
N/A
Research and Development Centers
11 (FY, 2021)
Research and Development Centers
N/A
Research and Development Centers
N/A
Research and Development Centers
N/A
Suppliers
Suppliers
N/A
Suppliers
N/A
Suppliers
N/A
Suppliers
N/A
Suppliers
N/A
Suppliers
68 k (FY, 2019)
Suppliers
N/A
Suppliers
N/A
Suppliers
N/A
Suppliers
93.8 k (FY, 2021)
Suppliers
37.5 k (FY, 2021)
Suppliers
N/A
Trademarks
Trademarks
N/A
Trademarks
170 (Feb, 2021)
Trademarks
N/A
Trademarks
5.2 k (Feb, 2024)
Trademarks
N/A
Trademarks
N/A
Trademarks
N/A
Trademarks
N/A
Trademarks
N/A
Trademarks
1.5 k (FY, 2021)
Trademarks
N/A
Trademarks
N/A

Funding

Total funding raised
Total funding raised
N/A
Total funding raised
N/A
Total funding raised
N/A
Total funding raised
N/A
Total funding raised
$ 121m
Total funding raised
$ 310m
Total funding raised
$ 57.8m
Total funding raised
N/A
Total funding raised
$ 15.5m
Total funding raised
$ 3.5b
Total funding raised
N/A
Total funding raised
N/A
For sources of this data, please see the company profile

View Company Profiles

Bausch Health
HQ
Laval, CA
Employees
20,270

Bausch Health is a company that develops, manufactures, and markets a range of pharmaceutical, medical device, and over-the-counter (OTC) products.

View company
Astellas Pharma
HQ
Tokyo, JP
Employees
14,484

Astellas Pharma (アステラス製薬株式会社) is a pharmaceutical company focused on the development of drugs and medical solutions.

View company
Boehringer Ingelheim
HQ
Ingelheim am Rhein, DE

Boehringer Ingelheim International is a pharmaceutical company specializing in animal health, human pharma, and biopharmaceutical contract manufacturing.

View company
Merck Group
HQ
Darmstadt, DE
Employees
62,908↓ 1% decrease

Merck Group is a science and technology company.

View company